Shilpa Medicare Limited offers pharmaceutical ingredients (APIs), finished dosage formulations, biosimilars, and contract development and manufacturing organisation (CDMO) services in India, the United States, Europe, and internationally.
Shilpa Medicare Limited (SHILPAMED) is listed on the NSE in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry. The SHILPAMED share price is ₹940.05 (+0.01% today), with a market capitalisation of ₹184B and a price-to-earnings (P/E) ratio of 55.7. MarketRipple tracks the SHILPAMED investment thesis, the ripple-chain impact of market events on Shilpa Medicare Limited, and the Healthcare sector outlook.
Open
₹953.65
High
₹977.00
Low
₹931.00
Prev. Close
₹940.00
52W High
₹1,095.00
52W Low
₹259.50
Day range
₹931.00–₹977.00
52-week range
₹259.50–₹1,095.00
Volume
429K
P/E
55.7
ROE
12.8%
D/E
0.25
Margin
18.0%
Shilpa Medicare Limited (NSE: SHILPAMED) is currently trading at ₹940.05 (+0.01%).
Shilpa Medicare Limited's market capitalization is ₹184B.
Shilpa Medicare Limited's price-to-earnings (P/E) ratio is 55.7.
Shilpa Medicare Limited operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic).
Analyst consensus on Shilpa Medicare Limited currently reads strongly positive, based on 4 analysts covering the stock. This is third-party analyst data, not a MarketRipple recommendation.